Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Type of content
Search
524 result(s) found, displaying 251 to 275
-
Market actionsRecall for product correction due to potential for interruption of medicine delivery and/or infection due to needle breaking during use.
-
Market actionsRecall for product correction due to potential for interruption of insulin delivery and/or infection due to needle breaking during use.
-
Market actionsMultiple devices which use auto servo ventilation/Adaptive Servo-Ventilation (ASV) therapy have been subject to recall actions.
-
Market actionsRecall for product correction due to increased risk of death for patients with symptomatic chronic heart failure.
-
Market actionsRecall for product correction due to additional affected devices.
-
Market actionsRecall as pumps will cease operation on 1 January 2016.
-
Market actionsRecall - risk of adverse events due to unacceptably high level of arsenic
-
Market actionsHazard alert due to multiple potential safety issues.
-
Market actionsRecall for product correction due to fire risk from faulty component.
-
Market actionsRecall for product correction due to fire risk from faulty component.
-
Market actionsThe following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall for product correction due to risk of sparking or fire due to damaged or cut wire.
-
Market actionsRecall for product correction due to potential for insulin to not be delivered as intended.
-
Market actionsRecall due to counterfeit products may have defects and not be effective.
-
Market actionsUpdate - recall for product correction - advertisements published to inform all affected users
-
Market actionsRecall due to incorrect contact lenses supplied to some consumers.
-
Market actionsRecall due to risk of adverse events due to potential dilution.
-
Market actionsHazard alert due to higher-than-expected revision rate.
-
Market actionsHazard alert due to potential for implant failure due to loosening.
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps